All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @chris_practical on TikTok · 66s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @chris_practical's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Many clinics will put you onto H.C.G. or even in Chlomaphine when TRT seems to fall short in the bedroom.
  2. 0:07So why does it work for some of you while others of you have to end up working with me?
  3. 0:12The primary reason it seems to work isn't because it mildly increases your test, pregnant alone or DHEA, although it plays some role.
  4. 0:21It seems to work because of something I consistently said.
  5. 0:25DHT seems to fall short in a lot of TRT protocols.
  6. 0:31H.C.G. seems to up-regulate five alpha reductase and three beta HSD in the scrotum.
  7. 0:38That means more DHEA is produced internally and more DHT is produced.
  8. 0:44DHEA supplement is another one.
  9. 0:46You guys are all like, hey, this has worked for me.
  10. 0:48And that's because one, it's a neuro steroid, which is important, of course, but also because it converts to DHT.
  11. 0:55In short, H.C.G. increases DHT, not that DHEA or pregnant alone is useless.
  12. 1:01If you're still not where you'd like to be in the bedroom, DM me excitement and maybe I can help.

@chris_practical's TRT libido claims need more context

chris_practical

TikTok creator

15.4K viewsWatch on TikTok

Quick answer

Men on exogenous testosterone often experience libido issues despite normal or supraphysiologic serum testosterone levels, likely because exogenous T suppresses intratesticular steroidogenesis and reduces production of pregnenolone, progesterone, and DHT that would normally be produced by Leydig cells under LH stimulation. HCG, as an LH analog, can partially restore this intratesticular hormonal milieu, which may explain anecdotal libido improvements beyond what serum testosterone levels would predict. However, the specific claim that upregulated 5-alpha reductase and elevated DHT are the primary mechanism remains mechanistically plausible but not confirmed in controlled clinical trials.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @chris_practical's TRT libido claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@chris_practical's TRT libido claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@chris_practical's TRT libido claims need more context" from chris_practical. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Men on exogenous testosterone often experience libido issues despite normal or supraphysiologic serum testosterone levels, likely because exogenous T suppresses intratesticular steroidogenesis and reduces production of pregnenolone, progesterone, and DHT that would normally be produced by Leydig cells under LH stimulation.

The reason this review is not generic is the source wording and the canonical claim label "trt libido is one of the more complex trt trt complications." In this clip, the useful excerpt is: "Many clinics will put you onto H." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

5-alpha reductase activity in testicular tissue is real and LH-dependent, giving the DHT-via-HCG hypothesis biological plausibility, but no controlled trial has confirmed DHT as the primary libido mediator from HCG use.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Men on exogenous testosterone often experience libido issues despite normal or supraphysiologic serum testosterone levels, likely because exogenous T suppresses intratesticular steroidogenesis and reduces production of pregnenolone, progesterone, and DHT that would normally be produced by Leydig cells under LH stimulation.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Men on exogenous testosterone often experience libido issues despite normal or supraphysiologic serum testosterone levels, likely because exogenous T suppresses intratesticular steroidogenesis and reduces production of pregnenolone, progesterone, and DHT that would normally be produced by Leydig cells under LH stimulation. HCG, as an LH analog, can partially restore this intratesticular hormonal milieu, which may explain anecdotal libido improvements beyond what serum testosterone levels would predict. However, the specific claim that upregulated 5-alpha reductase and elevated DHT are the primary mechanism remains mechanistically plausible but not confirmed in controlled clinical trials.
  • HCG acts as an LH analog and restores intratesticular steroidogenesis suppressed by exogenous testosterone, producing hormones beyond testosterone including pregnenolone, progesterone, and DHT that standard TRT does not replace.
  • 5-alpha reductase activity in testicular tissue is real and LH-dependent, giving the DHT-via-HCG hypothesis biological plausibility, but no controlled trial has confirmed DHT as the primary libido mediator from HCG use.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • HCG acts as an LH analog and restores intratesticular steroidogenesis suppressed by exogenous testosterone, producing hormones beyond testosterone including pregnenolone, progesterone, and DHT that standard TRT does not replace.
  • 5-alpha reductase activity in testicular tissue is real and LH-dependent, giving the DHT-via-HCG hypothesis biological plausibility, but no controlled trial has confirmed DHT as the primary libido mediator from HCG use.
  • 3-beta HSD is an enzyme involved in early steroidogenesis converting pregnenolone to progesterone and DHEA to androstenedione, not a direct step in DHT synthesis; the creator conflates it slightly with the 5-alpha reductase pathway.
  • DHEA is both a peripheral androgen precursor and a neuroactive steroid with documented CNS receptor activity (Baulieu et al., 1998, PNAS), but its conversion to DHT in men on TRT is modest compared to its conversion to androstenedione.
  • Libido on TRT is multifactorial. Serum testosterone, DHT, estradiol balance, prolactin, thyroid function, dopaminergic tone, sleep quality, and psychological factors all contribute, and no single biomarker reliably predicts subjective libido response.
  • Men experiencing persistent low libido on TRT should work with a physician to evaluate a full hormone panel including free testosterone, estradiol, DHT, prolactin, and thyroid, rather than attributing the issue to one pathway.
  • Anecdotal reports of HCG or DHEA improving libido are consistent with plausible mechanisms, but plausible mechanisms and patient testimonials are not substitutes for controlled evidence when making clinical decisions.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @chris_practical actually say?

The core claim here is that HCG improves libido on TRT not primarily because it raises testosterone, but because it upregulates 5-alpha reductase and 3-beta HSD activity in the scrotum, which increases local DHT production. He also argued that DHEA supplements help libido partly because they "convert to DHT" and act as a neurosteroid. His bottom line: "HCG increases DHT" is the mechanism that matters.

To his credit, he's not overselling a simple fix. He acknowledges that pregnenolone and DHEA "play some role" without being the whole story. The framing is more nuanced than most TRT influencer content. But nuanced framing doesn't mean the biochemistry is accurate, and some of it here deserves real scrutiny.

Does the science back this up?

Partially, yes, but the DHT story is more complicated than he makes it sound. The claim that HCG upregulates intratesticular 5-alpha reductase activity has biological plausibility, and there is some supporting evidence. But calling DHT the primary driver of libido on TRT is a significant overclaim given what the literature actually shows.

LH receptor stimulation by HCG does influence intratesticular steroidogenesis beyond just testosterone production. Traish et al. (2007, Journal of Andrology) documented that DHT plays a role in male sexual function, but the relationship between circulating or local DHT and subjective libido is not cleanly dose-dependent. A 2021 review by Kovac and Lipshultz in Translational Andrology and Urology noted that libido is regulated by a network of androgens, neurosteroids, dopaminergic signaling, and psychosocial factors. Pointing at DHT as the primary lever is too clean.

On DHEA: it does convert peripherally to androgens including androstenedione and, to a lesser extent, testosterone and DHT. The neurosteroid claim is also real. Baulieu et al. (1998, PNAS) identified DHEA and DHEAS as neuroactive steroids with CNS effects. But the magnitude of DHT conversion from oral DHEA supplementation in adult men is modest and variable.

What did they get wrong (or right)?

He got the general direction right: HCG does more than just replace LH signaling, and intratesticular steroidogenesis produces compounds beyond testosterone that matter. That's a legitimate and often-ignored point in TRT discussions. Credit where it's due.

What's weaker is the confident mechanistic precision. The claim that HCG works "because of" DHT via 5-alpha reductase upregulation in the scrotum is stated as established fact. It isn't. The 3-beta HSD claim is also slightly misapplied here: 3-beta HSD is involved in converting pregnenolone to progesterone and DHEA to androstenedione, not directly in DHT synthesis. That step belongs to 5-alpha reductase acting on testosterone. Conflating these enzymatic steps suggests the explanation is being retrofitted onto a clinical observation rather than derived from solid mechanistic data.

The DHEA-to-DHT conversion pathway he describes is real but overstated. In practice, oral DHEA raises DHEAS and androstenedione more reliably than it raises DHT, particularly in eugonadal or TRT-supplemented men where feedback is already altered.

What should you actually know?

If your libido is still suboptimal on standard TRT, the honest answer is that no one fully knows why, and it's rarely one molecule. Morgentaler and Traish (2009, European Urology) noted that androgen effects on libido involve both peripheral and central mechanisms that don't map cleanly onto any single hormone level.

HCG does preserve intratesticular steroidogenesis and maintains production of hormones that exogenous testosterone suppresses, including pregnenolone, progesterone, and yes, some additional DHT. Whether that DHT increase is the reason libido improves for some men, versus the neurosteroid effects of restored pregnenolone or simply the psychological effect of feeling more hormonally complete, has not been cleanly separated in clinical trials.

DHEA supplementation shows inconsistent results in men. Some studies show modest libido improvement (Reiter et al., 1999, Journal of Clinical Endocrinology and Metabolism), others show no significant effect. The neurosteroid angle is biologically real but clinically unproven as a reliable libido driver in men on TRT.

The takeaway: the DHT hypothesis for HCG and libido is plausible and worth your doctor's attention, but it's a hypothesis, not settled science. Be skeptical of anyone, including well-meaning creators, who turns a plausible mechanism into a confident clinical explanation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

chris_practical · TikTok creator

15.4K views on this video

Libido is one of the more complex TRT/ TRT+ complications.

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about hcg acts as an lh analog?

HCG acts as an LH analog and restores intratesticular steroidogenesis suppressed by exogenous testosterone, producing hormones beyond testosterone including pregnenolone, progesterone, and DHT that standard TRT does not replace.

What does the video say about 5-alpha reductase activity in testicular tissue?

5-alpha reductase activity in testicular tissue is real and LH-dependent, giving the DHT-via-HCG hypothesis biological plausibility, but no controlled trial has confirmed DHT as the primary libido mediator from HCG use.

What does the video say about 3-beta hsd?

3-beta HSD is an enzyme involved in early steroidogenesis converting pregnenolone to progesterone and DHEA to androstenedione, not a direct step in DHT synthesis; the creator conflates it slightly with the 5-alpha reductase pathway.

What does the video say about dhea?

DHEA is both a peripheral androgen precursor and a neuroactive steroid with documented CNS receptor activity (Baulieu et al., 1998, PNAS), but its conversion to DHT in men on TRT is modest compared to its conversion to androstenedione.

What does the video say about libido on trt?

Libido on TRT is multifactorial. Serum testosterone, DHT, estradiol balance, prolactin, thyroid function, dopaminergic tone, sleep quality, and psychological factors all contribute, and no single biomarker reliably predicts subjective libido response.

What does the video say about men experiencing persistent low libido on trt should work with?

Men experiencing persistent low libido on TRT should work with a physician to evaluate a full hormone panel including free testosterone, estradiol, DHT, prolactin, and thyroid, rather than attributing the issue to one pathway.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by chris_practical, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.